ארלזי 25 Izrael - hebrajski - Ministry of Health

ארלזי 25

novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 25 mg / 0.5 ml - etanercept

ארלזי 50 Izrael - hebrajski - Ministry of Health

ארלזי 50

novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg / 1 ml - etanercept

טריפראטייד קמהדע Izrael - hebrajski - Ministry of Health

טריפראטייד קמהדע

kamada ltd, israel - teriparatide - תמיסה להזרקה - teriparatide 0.250 mg / 1 ml - teriparatide

סטימופג Izrael - hebrajski - Ministry of Health

סטימופג

tzamal bio-pharma ltd - pegfilgrastim - תמיסה להזרקה - pegfilgrastim 10 mg/ml - pegfilgrastim

פגפילגרסטים קמהדע Izrael - hebrajski - Ministry of Health

פגפילגרסטים קמהדע

kamada ltd, israel - pegfilgrastim - תמיסה להזרקה - pegfilgrastim 10 mg/ml - pegfilgrastim

הפאגם B Izrael - hebrajski - Ministry of Health

הפאגם b

tzamal bio-pharma ltd - hepatitis b immunoglobulin - תמיסה להזרקה - hepatitis b immunoglobulin 312 iu/ml - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b recurrence following liver transplantation : hepagam b is indicated for the prevetion of hepatitis b recurrence following liver transplantation in hbsag-positive liver transplant patients. hepagam b should be administered intravenously for this indication.postexposure prophylaxis : hepagam b is indicated for the treatment of acute exposure to blood containing hbsag perinatal exposure of infants born to hbsag-positive mothers sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick bite sharps) direct mucous membrane contact (accidental splash) or oral ingestion (pipetting accident) involving hbsag - positive materials such as blood plasma or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag. perinatal exposure of infants born to hbsag-positive